Zacks Company Profile for Applied DNA Sciences Inc (APDN : NSDQ) |
|
|
|
Company Description |
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
Number of Employees: 48 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $5.34 |
Daily Weekly Monthly
 |
20 Day Moving Average: 161,806 shares |
Shares Outstanding: 0.44 (millions) |
Market Capitalization: $2.32 (millions) |
Beta: 0.07 |
52 Week High: $2,655.00 |
52 Week Low: $4.37 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
5.33% |
1.38% |
12 Week |
-56.08% |
-63.06% |
Year To Date |
-96.51% |
-96.73% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
James A. Hayward - Chief Executive Officer and Chairman
Judith Murrah - President; Chief Operating Officer; Chief Informat
Beth Jantzen - Chief Financial Officer
Robert B. Catell - Director
Joseph D. Ceccoli - Director
|
|
Peer Information
Applied DNA Sciences Inc (BRC)
Applied DNA Sciences Inc (ALGI)
Applied DNA Sciences Inc (SYNX.)
Applied DNA Sciences Inc (ADSV)
Applied DNA Sciences Inc (CDCY)
Applied DNA Sciences Inc (CSCQ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: PROTECTION-SFTY
Sector: Industrial Products
CUSIP: 03815U607
SIC: 8734
|
|
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 0.44
Most Recent Split Date: 6.00 (0.07:1)
Beta: 0.07
Market Capitalization: $2.32 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/14/25 |
|
|
|
|